Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine

Psychopharmacology

Volumn 148, Issue 4, 2000, Pages 423-429

  Cartmell, Jayne ^a   Monn, James A ^a   Schoepp, Darryle D ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Behavior; Clozapine; LY379268; Metabotropic glutamate receptor; PCP; Psychosis

Indexed keywords

4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; CLOZAPINE; DRUG VEHICLE; GLUTAMATE RECEPTOR AGONIST; METABOTROPIC RECEPTOR; NEUROLEPTIC AGENT; PHENCYCLIDINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG SELECTIVITY; DRUG SPECIFICITY; DRUG TARGETING; EVOKED MUSCLE RESPONSE; LOCOMOTION; MALE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

EID: 0034068655     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050072     Document Type: Article

References (21)

1. Cartmell J, Monn JA, Schoepp, DD (1999) The mGlu2/3 receptor agonists, LY354740 and LY379268, selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. J Pharmacol Exp Ther 291:161-170
2. Castellani S, Adams PM (1981) Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur J Pharmacol 73:143-154
3. Conn PJ, Pin J-P (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37: 205-237
4. Dickson PR, Lang CG, Hinton SC, Kelley AE (1994) Oral stereotypy induced by amphetamine microinjection into striatum: an anatomical mapping study. Neuroscience 61:81-91
5. Halberstadt AL (1995) The phencyclidine-glutamate model of schizophrenia. Clin Neuropharmacol 18:237-249
6. Iwamoto ET (1984) An assessment of the spontaneous activity of rats administered morphine, phencyclidine, or nicotine using automated and observational methods. Psychopharmacology 84:374-382
7. Javitt DC (1987) Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J Clin Psychiatr 9:12-35
8. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308
9. Kitaichi K, Yamada K, Hasegawa T, Furukawa H, Nabeshima T (1994) Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin. Jpn J Pharmacol 66:181-189
10. Luby ED, Cohen BD, Rosenbaum G, Gottlieb, JS, Kelley R (1959) Study of a new schizophrenomimetic drug - Sernyl. Arch Neurol Psychiatr 81:113-119
11. Moghaddam B, Addams BK (1998) Reversal of phencyclidine effects by a group II metabotropic receptor agonist in rats. Science 281:1349-1351
12. Monn JA, Valli MJ, Massey SM, Hansen MM, Kress TJ, Wepsiec JP, Grutsch JL, Wright RA, Johnson BG, Andis SL, Kingston AE, Tomlinson R, Lewis R, Griffey KR, Tizzano JP, Schoepp DD (1999) Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors. J Med Chem 42:1027-1040
13. Murray TF, Horita A (1979) Phencyclidine-induced stereotyped behavior in rats: dose response effects and antagonism by neuroleptics. Life Sci 24:2217-2226
14. Nabeshima T, Yamada K, Yamaguchi K, Hiramatsu M, Furukawa H, Kameyama T (1983a) Effect of lesions in the striatum, nucleus accumbens and medial raphe on phencyclidine-induced sterotypied behaviors and hyperactivity in rats. Eur J Pharmacol 91:455-462
15. Nabeshima T, Yamaguchi K, Yamada K, Hiramatsu M, Furukawa H, Kameyama T (1983b) Phencyclidine-induced stereotyped behaviors in rats following specific neurotoxin lesions of the striatum. Eur J Pharmacol 93:229-234
16. Ohishi H, Shigemoto R, Nakanishi S, Mizuno N (1993a) Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience 53:1009-1018
17. Ohishi H, Shigemoto R, Nakanishi S, Mizuno N (1993b) Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study. J Comp Neurol 335:252-266
18. Petralia RS, Wang Y-X, Niedzielski AS, Wenthold RJ (1996) The metabotropic glutamate receptors, mGlu2 and mGlu3, show unique postsynaptic, presynaptic and glial localizations. Neuroscience 71:949-976
19. Sturgeon RD, Fessier RG, Meltzer HY (1979) Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur J Pharmacol 59: 169-179
20. Testa CM, Standaert DG, Young AB, Penney JB (1994) Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J Neurosci 14:3005-3018
21. 1 receptor and of catecholaminergic systems in the behavioral response to 8-hydroxy-2(di-n-propylamino)tetralin. Eur J Pharmacol 106:271-282